Gathering together on the shareholder list, public fund institutions closely monitor performance realization.

As of August 6, over a hundred A-share listed companies in the entire market have disclosed their semi-annual reports for 2026. Data shows that among the top ten shareholders of listed companies such as Zejing Pharmaceuticals, Shijia Photon, Dingtong Technology, and Keda Intelligent, public mutual fund products occupy half or more of the positions. Some fund analysts have noted that significantly buying in until becoming a top ten shareholder often indicates that fund managers have a particularly optimistic view of this investment opportunity. What factors have led public mutual fund products to collectively enter the market? Looking at the semi-annual report performance, these companies generally exhibit characteristics of high net profit growth or entering an inflection point of profitability. This aligns perfectly with the growth investment style that the public mutual fund industry has valued in recent years.